minoxidil has been researched along with dutasteride in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (12.50) | 29.6817 |
2010's | 13 (54.17) | 24.3611 |
2020's | 8 (33.33) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bandaranayake, I; Mirmirani, P | 1 |
Avram, MR; Rogers, NE | 1 |
Alsantali, A; Shapiro, J | 1 |
Rathnayake, D; Sinclair, R | 1 |
Bergstrom, KG | 1 |
Banka, N; Bunagan, MJ; Shapiro, J | 1 |
Basra, MK; Bhatti, HA; Patel, GK | 1 |
Nusbaum, AG; Nusbaum, BP; Rose, PT | 1 |
Torres, F | 1 |
Ioannides, D; Lazaridou, E | 1 |
Cranwell, WC; Sinclair, R | 1 |
Blume-Peytavi, U; Blumeyer, A; Del Marmol, V; Dobos, G; Finner, A; Kanti, V; Messenger, A; Nast, A; Piraccini, BM; Reygagne, P; Tosti, A; Trakatelli, M | 1 |
Dotzert, MS; Gupta, AK; Mays, RR; Piguet, V; Shear, NH; Versteeg, SG | 1 |
Amoh, Y; Inui, S; Itami, S; Ito, T; Kono, T; Kurata, S; Manabe, M; Nakamura, M; Narusawa, H; Ohyama, M; Osada, SI; Saito, N; Sato, A; Shimomura, Y; Tsuboi, R; Ueki, R; Yamazaki, M | 1 |
Kochhar, A; Tai, T | 1 |
Dommasch, ED; Gao, JL; Peebles, JK; Streed, CG; Thompson, J | 1 |
Bamimore, MA; Gupta, AK; Talukder, M; Venkataraman, M | 1 |
Boland-Rodriguez, E; Le Voti, F; Rodríguez-León, S; Sinclair, RD; Vano-Galvan, S; Villarreal-Villarreal, CD | 1 |
Gómez-Flores, M; Herz-Ruelas, ME; Martínez-Moreno, A; Ocampo-Candiani, J; Ocampo-Garza, J; Ocampo-Garza, SS; Orizaga-Y-Quiroga, TL; Sánchez-Meza, E | 1 |
Gupta, AK; Talukder, M; Williams, G | 1 |
Domínguez-Santas, M; Grimalt, R; Saceda-Corralo, D; Vañó-Galván, S | 1 |
Alhanshali, L; Buontempo, M; Lo Sicco, K; Majerson, D; Shapiro, J | 1 |
15 review(s) available for minoxidil and dutasteride
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Hair loss remedies--separating fact from fiction.
Topics: Alopecia; Azasteroids; Dietary Supplements; Dutasteride; Enzyme Inhibitors; Female; Finasteride; Humans; Low-Level Light Therapy; Male; Mineralocorticoid Receptor Antagonists; Minoxidil; Spironolactone; Treatment Outcome; Vasodilator Agents | 2004 |
Medical treatments for male and female pattern hair loss.
Topics: Adult; Alopecia; Androgen Antagonists; Azasteroids; Drug Therapy, Combination; Dutasteride; Female; Finasteride; Hair; Humans; Hyperhidrosis; Ketoconazole; Male; Minoxidil; Phototherapy; Prostate; Sperm Count; Tretinoin | 2008 |
Androgens and hair loss.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Administration, Cutaneous; Alopecia; Androgens; Animals; Azasteroids; Dutasteride; Enzyme Inhibitors; Finasteride; Genetic Predisposition to Disease; Hair; Humans; Male; Minoxidil; Risk Factors; Testosterone; Treatment Outcome | 2009 |
Male androgenetic alopecia.
Topics: Administration, Oral; Administration, Topical; Alopecia; Androgen Receptor Antagonists; Azasteroids; Combined Modality Therapy; Dutasteride; Finasteride; Genetic Predisposition to Disease; Hair; Humans; Male; Men's Health; Minoxidil; Polymorphism, Genetic; Receptors, Androgen | 2010 |
Pattern hair loss in men: diagnosis and medical treatment.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgens; Azasteroids; Dutasteride; Female; Finasteride; Genetic Predisposition to Disease; Hair Follicle; Humans; Male; Minoxidil; Vasodilator Agents | 2013 |
Hair restoration approaches for early onset male androgenetic alopecia.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Azasteroids; Cosmetic Techniques; Drug Therapy, Combination; Dutasteride; Finasteride; Hair Follicle; Humans; Male; Minoxidil; Tissue and Organ Harvesting; Vasodilator Agents | 2013 |
Nonsurgical therapy for hair loss.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Azasteroids; Combined Modality Therapy; Dutasteride; Female; Finasteride; Humans; Low-Level Light Therapy; Male; Minoxidil; Sex Factors | 2013 |
Androgenetic, diffuse and senescent alopecia in men: practical evaluation and management.
Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Alopecia; Dutasteride; Finasteride; Hair; Humans; Male; Minoxidil; Vasodilator Agents | 2015 |
Female pattern hair loss.
Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Alopecia; Androgen Antagonists; Androgen Receptor Antagonists; Antifungal Agents; Cyproterone Acetate; Dutasteride; Female; Finasteride; Flutamide; Hair; Humans; Ketoconazole; Minoxidil; Postmenopause; Spironolactone; Vasodilator Agents | 2015 |
Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Dutasteride; Finasteride; Humans; Low-Level Light Therapy; Minoxidil; Network Meta-Analysis; Platelet-Rich Plasma; Vasodilator Agents | 2018 |
Physiology and Medical Treatments for Alopecia.
Topics: Alopecia; Dihydrotestosterone; Dutasteride; Finasteride; Hair Preparations; Humans; Low-Level Light Therapy; Minoxidil | 2020 |
Androgenetic alopecia in transgender and gender diverse populations: A review of therapeutics.
Topics: Alopecia; Dutasteride; Finasteride; Humans; Minoxidil; Transgender Persons; Treatment Outcome | 2023 |
Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis.
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Bayes Theorem; Dutasteride; Finasteride; Humans; Male; Minoxidil; Network Meta-Analysis; Treatment Outcome; Young Adult | 2022 |
Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Dutasteride; Finasteride; Hair; Humans; Male; Minoxidil | 2022 |
1 trial(s) available for minoxidil and dutasteride
Article | Year |
---|---|
Microneedling plus topical dutasteride solution for androgenetic alopecia: a randomized placebo-controlled study.
Topics: Administration, Topical; Alopecia; Double-Blind Method; Dutasteride; Finasteride; Humans; Minoxidil; Treatment Outcome | 2022 |
8 other study(ies) available for minoxidil and dutasteride
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
What's new in androgenetic alopecia: approvals, long-term safety data, cancer risk and treatment options for women.
Topics: Alopecia; Azasteroids; Drug Approval; Drug-Related Side Effects and Adverse Reactions; Dutasteride; Female; Finasteride; Humans; Male; Minoxidil; Neoplasms; Risk Factors; Time Factors | 2011 |
Familial frontal fibrosing alopecia treated with dutasteride, minoxidil and artificial hair transplantation.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Dutasteride; Female; Fibrosis; Folliculitis; Forehead; Humans; Middle Aged; Minoxidil; Prostheses and Implants; Vasodilator Agents | 2017 |
Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Drug Therapy, Combination; Dutasteride; Evidence-Based Medicine; Female; Finasteride; Hair; Humans; Low-Level Light Therapy; Male; Minoxidil; Outcome Assessment, Health Care; Platelet-Rich Plasma; Practice Guidelines as Topic; Vasodilator Agents | 2018 |
Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version.
Topics: Adenosine; Administration, Oral; Administration, Topical; Alopecia; Dutasteride; Female; Finasteride; Hair; Humans; Japan; Lasers, Semiconductor; Low-Level Light Therapy; Male; Minoxidil; Sex Factors; Treatment Outcome | 2018 |
Dutasteride intralesional microinjections in combination with oral minoxidil vs. oral minoxidil monotherapy in men with androgenetic alopecia: a retrospective analysis of 105 patients.
Topics: Alopecia; Dutasteride; Humans; Male; Microinjections; Minoxidil; Retrospective Studies; Treatment Outcome | 2022 |
What's New in Therapy for Male Androgenetic Alopecia?
Topics: Alopecia; Dutasteride; Finasteride; Humans; Male; Minoxidil; Retrospective Studies; Treatment Outcome | 2023 |
Intradermal Delivery of Alopecia Therapeutics: Current State and Future Prospects.
Topics: Alopecia; Drug-Related Side Effects and Adverse Reactions; Dutasteride; Humans; Mesotherapy; Minoxidil; Treatment Outcome | 2023 |